Company / R&D per Share
Axogen, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.74
FY2025
5-year range
$0.43 / $0.74
FY2021-FY2025
Trend
+15.7%
vs FY2024
Sector context
#78 of 108
Health Care
What the data says
At $0.74, Axogen, Inc.'s r&d per share ranks #78 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.11 in FY2016 to $0.74 in FY2025.
Based on SEC 10-K filings.
0.74 in FY2025 with a 5-year CAGR of +20.2%.
Improved from $0.64 to $0.74 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +20.3%
- 5-Year CAGR
- +20.2%
- 10-Year CAGR
- -
Sector benchmark
#78 of 108 in Health CareTop 72% of 108This company $0.74 Sector average $2.07
▼
-64.1% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 15.7% year-over-year.
- Ranks #78 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- Negative profit margin: -5.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.74 | +15.7% |
| FY2024 | $0.64 | -0.0% |
| FY2023 | $0.64 | +50.6% |
| FY2022 | $0.43 | -0.8% |
| FY2021 | $0.43 | +45.0% |
| FY2020 | $0.30 | -33.9% |
| FY2019 | $0.45 | +267.2% |
| FY2018 | $0.12 | -39.6% |
| FY2017 | $0.20 | +88.0% |
| FY2016 | $0.11 | -35.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026